Type 1 is defined by the loss of insulin production by the pancreas and type 2 is defined by loss of peripheral responses to insulin
10.1097/MED.0000000000000578 Curr
S., Gorthi, A., Bernard, X
Kidney Int 57:526533 Chittur SV, Klem TJ, Shafer CM, Davisson VJ (2001) Mechanism for acivicin inactivation of triad glutamine amidotransferases
Factors such as patient preferences, frequency of dosing, comorbidities, and the primary goals of treatment whether focused on glycemic control, weight loss, or a combination of both play pivotal roles in guiding healthcare professionals and patients towards the most suitable therapeutic option
PlexusDx recommends gradual dose tapering over 48 weeks, intensified protein intake, consistent exercise, and the Precision Peptide Genetic Test to understand whether your genetic profile predisposes you to stronger appetite rebound